Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Kaveri Pohlman's Stock Ratings
Clear Street Analyst
Kaveri Pohlman is an analyst at Clear Street. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-8.37%
Smart Score
Overall Average Return Percentile
20th
Number of Ratings
40
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/09/2025 | GPCR | Buy Now | Structure Therapeutics | $64.35 | 53.85% | $61 → $99 | Maintains | Buy | Get Alert | |
| 12/05/2025 | PVLA | Buy Now | Palvella Therapeutics | $88.75 | 125.35% | → $200 | Initiates | → Buy | Get Alert | |
| 12/02/2025 | JANX | Buy Now | Janux Therapeutics | $14.88 | 115.05% | $80 → $32 | Maintains | Buy | Get Alert | |
| 11/25/2025 | JBIO | Buy Now | Jade Biosciences | $15.25 | 63.93% | → $25 | Initiates | → Buy | Get Alert | |
| 11/14/2025 | TRVI | Buy Now | Trevi Therapeutics | $12.81 | 63.93% | $11 → $21 | Maintains | Buy | Get Alert | |
| 11/13/2025 | ZURA | Buy Now | Zura Bio | $4.07 | 342.26% | → $18 | Initiates | → Buy | Get Alert | |
| 10/22/2025 | SGMT | Buy Now | Sagimet Biosciences | $6.03 | 380.93% | → $29 | Initiates | → Buy | Get Alert | |
| 10/21/2025 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 99.93% | $41 → $60 | Maintains | Buy | Get Alert | |
| 10/01/2025 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 29.26% | → $11 | Initiates | → Buy | Get Alert | |
| 09/30/2025 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 36.62% | $24 → $41 | Maintains | Buy | Get Alert | |
| 09/17/2025 | ORKA | Buy Now | Oruka Therapeutics | $30.10 | 52.82% | $46 → $46 | Maintains | Buy | Get Alert | |
| 06/25/2025 | AVBP | Buy Now | ArriVent BioPharma | $23.58 | 35.71% | → $32 | Initiates | → Buy | Get Alert | |
| 08/01/2024 | MGNX | Buy Now | Macrogenics | $1.35 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 06/27/2024 | GMAB | Buy Now | Genmab | $31.49 | 49.25% | $46 → $47 | Maintains | Buy | Get Alert | |
| 05/24/2024 | MGNX | Buy Now | Macrogenics | $1.35 | 566.67% | $24 → $9 | Maintains | Buy | Get Alert | |
| 04/17/2024 | CGEM | Buy Now | Cullinan Oncology | $10.91 | 174.98% | $20 → $30 | Maintains | Buy | Get Alert | |
| 04/16/2024 | XNCR | Buy Now | Xencor | $16.79 | 126.33% | $56 → $38 | Maintains | Buy | Get Alert | |
| 03/26/2024 | NUVB | Buy Now | Nuvation Bio | $8.49 | -41.11% | → $5 | Upgrade | Neutral → Buy | Get Alert | |
| 03/21/2024 | JANX | Buy Now | Janux Therapeutics | $14.88 | 316.67% | → $62 | Initiates | → Buy | Get Alert | |
| 03/04/2024 | MGNX | Buy Now | Macrogenics | $1.35 | 1677.78% | $12 → $24 | Maintains | Buy | Get Alert | |
| 02/09/2024 | PYXS | Buy Now | Pyxis Oncology | $4.17 | 91.85% | → $8 | Initiates | → Buy | Get Alert | |
| 12/19/2023 | EXEL | Buy Now | Exelixis | $41.63 | -35.14% | → $27 | Initiates | → Buy | Get Alert | |
| 10/13/2023 | GMAB | Buy Now | Genmab | $31.49 | 46.08% | $44 → $46 | Maintains | Buy | Get Alert | |
| 09/12/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $26 | Initiates | → Buy | Get Alert | |
| 08/24/2023 | GMAB | Buy Now | Genmab | $31.49 | 39.73% | → $44 | Initiates | → Buy | Get Alert | |
| 08/23/2023 | RCUS | Buy Now | Arcus Biosciences | $21.91 | 219.49% | → $70 | Reiterates | Buy → Buy | Get Alert | |
| 03/21/2023 | MGNX | Buy Now | Macrogenics | $1.35 | 788.89% | $6 → $12 | Maintains | Buy | Get Alert | |
| 11/21/2022 | CGEM | Buy Now | Cullinan Oncology | $10.91 | 83.32% | → $20 | Initiates | → Buy | Get Alert | |
| 11/14/2022 | ONCS | Buy Now | OncoSec Medical | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 08/31/2022 | STTK | Buy Now | Shattuck Labs | $2.87 | 318.12% | → $12 | Initiates | → Buy | Get Alert | |
| 08/02/2022 | NUVB | Buy Now | Nuvation Bio | $8.49 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $4.12 | 94.17% | $16 → $8 | Maintains | Buy | Get Alert | |
| 06/01/2022 | NEXI | Buy Now | NexImmune | $0.01 | 49900% | → $5 | Initiates | → Buy | Get Alert | |
| 04/20/2022 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 03/30/2022 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | $29 → $9 | Maintains | Buy | Get Alert | |
| 03/16/2022 | ONCS | Buy Now | OncoSec Medical | — | — | $10 → $5 | Maintains | Buy | Get Alert | |
| 02/24/2022 | ONCT | Buy Now | Oncternal Therapeutics | — | — | → $5 | Initiates | → Buy | Get Alert | |
| 02/09/2022 | SONN | Buy Now | Sonnet BioTherapeutics | — | — | $5 → $2 | Maintains | Buy | Get Alert | |
| 11/15/2021 | CTMX | Buy Now | CytomX Therapeutics | $4.12 | 288.35% | → $16 | Initiates | → Buy | Get Alert | |
| 09/15/2021 | SONN | Buy Now | Sonnet BioTherapeutics | — | — | → $5 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved